Interaction between yohimbine alkaloids and amphetamine in mice.

Area of Science:

• Pharmacology
• Toxicology
• Neuroscience

Background:

• Yohimbine alkaloids are known for their complex pharmacological effects.
• Understanding the toxicity and interactions of yohimbine isomers with other drugs is crucial for safety and therapeutic potential.

Purpose of the Study:

• To determine the acute toxicity (LD50) of yohimbine, beta-yohimbine, and corynanthine in mice.
• To investigate the interactive toxicity between these yohimbine isomers and amphetamine.
• To elucidate the potential mechanisms underlying these interactions.

Main Methods:

• Acute toxicity (LD50) was assessed for individual yohimbine isomers and amphetamine in mice.
• Combined toxicity studies were performed using fixed doses of one compound and varying doses of the other.
• Isobolographic analysis was employed to evaluate the nature of drug interactions (potentiation or antagonism).

Main Results:

• Beta-yohimbine was approximately twice as toxic as yohimbine; corynanthine was about one-fifth as toxic.
• Yohimbine and beta-yohimbine showed mutual potentiation with amphetamine toxicity.
• Corynanthine antagonized amphetamine toxicity, indicating differential effects among isomers.

Conclusions:

• The toxicity of yohimbine isomers varies significantly, with beta-yohimbine being the most potent.
• Interactions between yohimbine isomers and amphetamine range from potentiation to antagonism.
• These interactions may involve serotonergic or dopaminergic pathways rather than solely noradrenergic mechanisms.